Pharmacogenomics: Clinical blueprint for individualised patient care
Codeine as a well-known example, pharmacogenomics had leapt forward along with the introduction of human genome project and bioinformatics since 1970s. Since then, pharmaceutical technology has developed rapidly aiming to increase the efficacy of drugs. Moreover, the currently increasing focus on patient-centered service has shed new light on pharmacogenomics. Tailored medication increases patient compliance and reduces the side effects of drugs. Especially, the aging society is looking forward to the application of pharmacogenomics to individualised medication to combat polypharmacy issues. Utilisation of pharmacogenomics is promising for its contribution to drug development and drug review which eventually aid to pursue personalised medication to improve quality of life.
Threats or Opportunities: Leading the way towards patient safety through innovative platforms for patient education
Along with the diverse health-related platforms that patients can reach out for these days, controversies over patient safety and the role of healthcare professionals are on the floor. Would the easier and faster access to health information be threats or opportunities? As a matter of fact, pharmacy professions can take a key role to navigate the appropriate approaches towards patient safety in this regard. Pharmacists can provide quality patient education and secure patient safety utilizing emerging platforms including digital healthcare. However, they also can degrade patient compliance and patient safety, if managed poorly without supervision of experts, including pharmacists. Being aware of which aspect of overflowing health data would harm and how to overcome it could be the first step to analyze the concerns. In the meantime, let’s scrutinize what we have in our hands. Are they really being threats? Or opportunities? – It may depend on how we think and prepare, holding fast to our accountability as medicine experts!